OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl‐CBMICA and Cumyl‐CBMINACA
Belal Haschimi, Katharina Elisabeth Grafinger, Benedikt Pulver, et al.
Drug Testing and Analysis (2021) Vol. 13, Iss. 8, pp. 1499-1515
Closed Access | Times Cited: 18

Showing 18 citing articles:

Synthetic Cannabinoids: A Pharmacological and Toxicological Overview
Rita Roque Bravo, Rafaela Sofia Silva, R.F. Malheiro, et al.
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 187-209
Open Access | Times Cited: 51

ADB‐HEXINACA—a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market
Arianna Giorgetti, Annette Zschiesche, Olwen Groth, et al.
Drug Testing and Analysis (2024) Vol. 16, Iss. 11, pp. 1350-1365
Open Access | Times Cited: 5

QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid
Annagiulia Di Trana, Giorgia Sprega, Giorgi Kobidze, et al.
Molecules (2024) Vol. 29, Iss. 14, pp. 3440-3440
Open Access | Times Cited: 5

EMCDDA framework and practical guidance for naming synthetic cannabinoids
Benedikt Pulver, Svenja Fischmann, Ana Gallegos, et al.
Drug Testing and Analysis (2022) Vol. 15, Iss. 3, pp. 255-276
Closed Access | Times Cited: 22

Ciências Forenses: Aplicações Científicas na Criminalística
Samara Alves Testoni, Cláudio M. P. Pereira, Rafael Scorsatto Ortiz
Revista Brasileira de Criminalística (2025) Vol. 14, Iss. 1, pp. 77-77
Open Access

The ADEBAR project: European and international provision of analytical data from structure elucidation and analytical characterization of NPS
Benedikt Pulver, Svenja Fischmann, Folker Westphal, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 8, pp. 1491-1502
Open Access | Times Cited: 11

Human phase‐I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F‐EDMB‐PICA and EDMB‐PINACA
Arianna Giorgetti, Pietro Brunetti, Belal Haschimi, et al.
Drug Testing and Analysis (2022) Vol. 15, Iss. 3, pp. 299-313
Open Access | Times Cited: 11

Narrative Review of the Pharmacodynamics, Pharmacokinetics, and Toxicities of Illicit Synthetic Cannabinoid Receptor Agonists
Matilda Houston, Jody Morgan, Céline Kelso
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 1, pp. 92-109
Closed Access | Times Cited: 5

Structure elucidation of the novel synthetic cannabinoid Cumyl‐Tosyl‐Indazole‐3‐Carboxamide (Cumyl‐TsINACA) found in illicit products in Germany
Benedikt Pulver, Torsten Schönberger, Diana Weigel, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 8, pp. 1387-1406
Closed Access | Times Cited: 8

Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA
Liesl K. Janssens, Adam Ametovski, Eric Sparkes, et al.
ACS Chemical Neuroscience (2022) Vol. 14, Iss. 1, pp. 35-52
Open Access | Times Cited: 6

Metabolism studies of 4′Cl‐CUMYL‐PINACA, 4′F‐CUMYL‐5F‐PINACA and 4′F‐CUMYL‐5F‐PICA using human hepatocytes and LC‐QTOF‐MS analysis
Dārta Štālberga, Sarah Ingvarsson, Ghidaa Bessa, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 132, Iss. 3, pp. 263-280
Open Access | Times Cited: 6

A new synthetic cathinone: 3,4‐EtPV or 3,4‐Pr‐PipVP? An unsuccessful attempt to circumvent the German legislation on new psychoactive substances
Benedikt Pulver, Jan Riedel, Folker Westphal, et al.
Drug Testing and Analysis (2022) Vol. 15, Iss. 1, pp. 84-96
Open Access | Times Cited: 5

Interpol review of toxicology 2019–2022
Jack Yuk-ki Cheng, Janesse Wing-Sze Hui, Wing-sum Chan, et al.
Forensic Science International Synergy (2022) Vol. 6, pp. 100303-100303
Open Access | Times Cited: 4

Synthesis and structure determination of a synthetic cannabinoid CUMYL‐THPINACA metabolite with differentiation between the ortho‐, meta‐, and para‐hydroxyl positions of the cumyl moiety
Yuki Azuma, Takahiro Doi, Akiko Asada, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 4, pp. 348-358
Closed Access | Times Cited: 1

Identification of 5F-Cumyl-PINACA, a Synthetic Cannabinoid, in the Herbal Material Used for Recreational Purposes in the Province of Trieste: Public Health Implications
Michela Peruch, Riccardo Addobbati, Martina Padovano, et al.
Current Pharmaceutical Biotechnology (2022) Vol. 24, Iss. 6, pp. 758-765
Closed Access | Times Cited: 1

Pharmacology, prevalence in Germany, and analytical data of cyclobutylmethyl‐ and norbornylmethyl‐type synthetic cannabinoid receptor agonists
Benedikt Pulver, Jan Riedel, Torsten Schönberger, et al.
Drug Testing and Analysis (2022) Vol. 15, Iss. 4, pp. 408-425
Open Access

Page 1

Scroll to top